MS in the Media - 15 March 2019
9 - 15 March 2019
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Worldwide prevalence of MS
A recently published study suggests that the prevalence of MS (number of people living the MS) has increased by 10.4% from 1990 to 2016. The regions with the highest prevalence rates are North America, Western Europe and Australasia.
Source: Neurology Advisor
MS Trust link: Prevalence and incidence of MS
United States National MS Society funds study of stem cells for progressive MS
The National MS Society in the USA is contributing $1 million to a phase 2 trial of mesenchymal stem cells to treat progressive forms of MS. The study is being undertaken at the Tisch Medical Center in New York.
Source: MS News Today
Source: National MS Society
MS Trust link: Stem cell therapy
Diagnosed at 25 years old
Andrew Knight talks about being diagnosed at 25 and how it’s affected him.
Source: BBC
MS Trust link: Personal stories
Childhood multiple sclerosis
Luke Merritt was diagnosed with MS at the age of 11; his family share their story about the challenges of parenting a child with MS.
Source: Yahoo Lifestyle
MS Trust link: Childhood MS
Dating and finding love after an MS diagnosis
Cory Martin shares her fears around dating following an MS diagnosis.
Source: Yahoo Lifestyle
MS Trust source: Telling people about MS
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
